Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Cameco Corporation · CCJ · FY2026 Q2 · Calendar Q3 2026
The call supports a constructive operating thesis: higher uranium prices, stronger nuclear policy support and Westinghouse growth provide demand support, while execution, project timing and cost risks remain material.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Management highlighted higher uranium spot and contract prices, increased ownership of Cigar Lake, a 91-reactor AP1000 pipeline, and a conditional $17.5 billion DOE loan commitment for AP1000 long-lead items.
The annual production outlook and capex plans were unchanged. Management said temporary access issues and a short Cigar Lake shutdown did not affect annual production guidance.
Follow CCJ with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 free1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Oct 22, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 19, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 9, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jun 29, 2026 |
| GLJ Research | Buy | Buy | Maintain | Feb 18, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 29, 2025 |
| Scotiabank | Outperform | Outperform | Maintain | Aug 19, 2024 |
| TD Securities | Action List Buy | Maintain | Oct 3, 2023 | |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 5, 2023 |
| Raymond James | Outperform | Outperform | Maintain | Aug 3, 2023 |
| BMO Capital | Outperform | Market Perform | Upgrade | Mar 31, 2022 |
| Bank of America | Underperform | Underperform | Maintain | Oct 4, 2017 |
| Credit Suisse | Underperform | Neutral | Downgrade | Jul 18, 2017 |
| CIBC | Outperform | Sector Perform | Upgrade | Apr 7, 2015 |
| Salman Partners | Buy | Hold | Upgrade | Oct 30, 2014 |
| Dundee | Buy | Neutral | Upgrade | Oct 9, 2014 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Aug 21, 2014 |
| Cantor Fitzgerald | Hold | Buy | Downgrade | Jul 25, 2014 |
| Cormark Securities | Market Perform | Buy | Downgrade | Feb 11, 2014 |
| UBS | Buy | Buy | Maintain | Aug 2, 2013 |
| JP Morgan | Neutral | Overweight | Downgrade | Nov 8, 2012 |
Upside is calculated against the persisted current price $76.91. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Christopher Souther | $125 | $82.02 | +62.5% | Oct 22, 2026 |
| Barclays | Analyst unavailable | $95 | $81.52 | +23.5% | Oct 19, 2026 |
| Jefferies | Analyst unavailable | $138 | $96.38 | +79.4% | Sep 3, 2026 |
| Truist Financial | Analyst unavailable | $130 | $99.31 | +69.0% | Aug 12, 2026 |
| Barclays | Analyst unavailable | $97 | $89.72 | +26.1% | Aug 4, 2026 |
| Barclays | Analyst unavailable | $104 | $91.57 | +35.2% | Jul 15, 2026 |
| Truist Financial | Analyst unavailable | $129 | $90.2 | +67.7% | Jul 13, 2026 |
| Bernstein | Bob Brackett | $135 | $106.96 | +75.5% | Jun 15, 2026 |
| Barclays | Analyst unavailable | $108 | $105.33 | +40.4% | May 21, 2026 |
| Scotiabank | Orest Wowkodaw | $175 | $114.46 | +127.5% | May 6, 2026 |
| Bernstein | Bob Brackett | $147 | $109.97 | +91.1% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $131 | $126.15 | +70.3% | Feb 4, 2026 |
| Bernstein | Analyst unavailable | $101 | $102.09 | +31.3% | Jan 7, 2026 |
| GLJ Research | Analyst unavailable | $99.74 | $86.85 | +29.7% | Dec 3, 2025 |
| Goldman Sachs | Analyst unavailable | $109 | $105.95 | +41.7% | Oct 29, 2025 |
| UBS | Analyst unavailable | $102 | $77.39 | +32.6% | Sep 9, 2025 |
| CLSA | Max Hopkins | $102 | $77.14 | +32.6% | Sep 9, 2025 |
| Bernstein | Bob Brackett | $70 | $63.83 | -9.0% | Jun 10, 2025 |
| Goldman Sachs | Neil Mehta | $55 | $43.32 | -28.5% | Apr 1, 2024 |
| Scotiabank | Orest Wowkodaw | $30.24 | $25.07 | -60.7% | Nov 1, 2021 |
| GLJ Research | Gordon Johnson | $30.24 | $19.11 | -60.7% | Sep 1, 2021 |
Track every rating change on CCJ the moment it posts. Free to start.
Start freeCameco Corporation is a prominent global enterprise specializing in the production and distribution of uranium. Its operations are structured into two core divisions: Uranium and Fuel Services. The Uranium division manages the full upstream process, encompassing the exploration, extraction, and initial processing (milling) of uranium ore, as well as the procurement and sale of uranium concentrate. Conversely, the Fuel Services division focuses on the downstream transformation of uranium. This includes the refining, conversion, and fabrication of uranium concentrate into usable forms, alongside providing related conversion services. Furthermore, this segment is responsible for manufacturing specialized fuel bundles and reactor components specifically designed for CANDU reactors. Cameco provides its essential uranium products and associated fuel services to nuclear utility clients across major international markets, including the Americas, Europe, and Asia. The company was founded in 1987 and maintains its principal office in Saskatoon, Canada.
| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CVX Chevron Corporation | FY2026 Q3 · Calendar Q4 2026 | +8.4% | +1.8% | Chevron posts strong Q3 as production, cash flow and AI value rise |
| XOM Exxonmobil Holdings Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.7% | +2.2% | ExxonMobil Highlights Refining, LNG and Cash Returns in Q3 |
| IMO Imperial Oil Limited | FY2026 Q3 · Calendar Q4 2026 | +6.4% | +5.5% | Imperial Oil: downstream strength and low-carbon growth lead Q3 |
| BP BP p.l.c. | FY2026 Q3 · Calendar Q4 2026 | +22.6% | +0.1% | BP Q3: Strong profit, lower debt, safety risks persist |
| FSLR First Solar, Inc. | FY2026 Q3 · Calendar Q4 2026 | +13.5% | -1.4% | First Solar: Margin gains offset lower volume outlook |
| SHEL Shell plc | FY2026 Q3 · Calendar Q4 2026 | +7.2% | +2.4% | Shell pairs strong Q3 with LNG expansion and portfolio deals |
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-31. For educational purposes only; not investment advice.